Quantcast

Latest Medical genetics Stories

2014-07-07 16:24:11

NEW YORK, July 7, 2014 /PRNewswire/ -- Lysosomal storage disorders are a group of approximately 50 rare inherited metabolic disorders resulting from defects in lysosomal function. These severe, chronic genetic diseases have unmet medical needs, and include Fabry disease, Gaucher disease, Parkinson's disease, Pompe disease, and Tay-Sachs disease. The market for current drug therapies to address these disorders is estimated to exceed $3 billion. Amicus Therapeutics, Inc. (NASDAQ:...

2014-07-07 08:27:30

NextCODE capabilities will power ACoRD/UCD leadership in sequence-based diagnostics and large-scale whole-genome discovery efforts in pediatric disorders CAMBRIDGE, Mass., July 7, 2014 /PRNewswire/ -- NextCODE Health, which puts whole-genome analysis in the hands of clinicians and researchers worldwide, today announced the start of a partnership with the Academic Centre on Rare Diseases (ACoRD) at University College Dublin. ACoRD will use NextCODE solutions to take full advantage...

2014-07-07 04:20:59

COPENHAGEN, July 7, 2014 /PRNewswire/ -- BGI Diagnostics' NIFTY(TM) test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA). On June 30, 2014, the CFDA approved the registration of BGI's BGISEQ-1000 and BGISEQ-100 sequencers, and its prenatal genetic testing kits for NIFTY(TM) (Non-Invasive Fetal Trisomy test). This is the first genetic test based on next generation sequencing technology to...

2014-06-30 12:32:22

NEW YORK, June 30, 2014 /PRNewswire/ -- FDNA(R) (http://www.fdna.com) - a pioneer in computer-aided dysmorphology analysis is proud to announce that four of Europe's leading thought leaders in genetics and human dysmorphology have been appointed to the steering committee of its Scientific Advisory Board (SAB). These appointments further strengthen the SABs strategic role in assisting FDNA on its mission to save lives and improve the quality of life of patients with rare or...

2014-06-24 23:05:08

GIA announces the release of a comprehensive global report on Genetic Testing markets. Global market for Genetic Testing is forecast to reach US$7.3 billion by 2020, driven by growing healthcare awareness, growing interest in genetic testing for accurate disease diagnosis and treatment decision-making, and favorable reimbursement coverage policies. San Jose, California (PRWEB) June 24, 2014 Follow us on LinkedIn – Almost every known disease, ranging from common maladies to...

2014-06-24 12:27:50

ST. PETERSBURG, Fla., June 24, 2014 /PRNewswire-USNewswire/ -- InformedDNA announced today a strategic new collaboration with Edimer Pharmaceuticals to address a critical research need for patients with X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder. The partnership will allow InformedDNA to identify patients with XLHED and support Edimer's clinical programs. Under the agreement, InformedDNA has developed a genetic counseling program for patients and...

2014-06-24 10:57:10

University of Oxford Computer analysis of photographs could help doctors diagnose which condition a child with a rare genetic disorder has, say Oxford University researchers. The researchers, funded in part by the Medical Research Council (MRC), have come up with a computer programme that recognises facial features in photographs; looks for similarities with facial structures for various conditions, such as Down's syndrome, Angelman syndrome, or Progeria; and returns possible matches...

2014-06-23 08:27:25

LEVERKUSEN, Germany, June 23, 2014 /PRNewswire/ -- Bayer HealthCare (Bayer) and Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, have entered into a collaboration for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. "Bayer is a worldwide leader in the treatment of hemophilia A and we are highly committed to advancing innovative treatment options for...

2014-06-21 08:20:25

Foundation Fighting Blindness Co-Founder and Chairman Gordon Gund and Family to Catalyze Retinal Degenerative Disease Research with Unlimited Donation Matching Challenge for Two Years COLUMBIA, Md., June 21, 2014 /PRNewswire/ -- In support of the fight to eradicate blindness, Foundation Fighting Blindness Chairman and Co-Founder Gordon Gund and his family announced a matching gift challenge they hope will result in millions of dollars in funds to accelerate pre-clinical,...

2014-06-19 08:28:26

RICHMOND, Calif., June 19, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the appointment of H. Stewart Parker to the Company's Board of Directors. Ms. Parker, who founded and served as President and CEO of Targeted Genetics Corporation, brings more than 30 years of experience in the biotechnology industry, including 16 years of specific experience in cell and gene therapy. http://photos.prnewswire.com/prnvar/20130102/SF35903LOGO "We are very pleased to...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.